PrecisionBiotics : Novozymes acquires PrecisionBiotics Group

Novozymes has acquired 100% of the equity in PrecisionBiotics Group Limited for an amount of DKK 600 million (EUR 80 million) on a cash and debt-free basis. The transaction is structured with an earn-out model, is financed with cash and bank facilities, and does not change the capital structure policy of Novozymes. The acquisition gives ...